Dedicated to finding a cure
JDRF is the worldwide leader in funding research to cure type 1 diabetes, an autoimmune disease that strikes children and adults suddenly and lasts a lifetime. JDRF sets the global agenda for diabetes research and is the largest charitable funder of and advocate for diabetes science worldwide.
JDRF’s mission has been constant since it was founded four decades ago: to find a cure for type 1 and its complications through the support of research. Until a cure is found, JDRF is also committed to working tirelessly to develop new and better treatments to improve the lives of people who have type 1 and keep them as healthy as possible.
Today, people with type 1 diabetes rely on insulin to manage the disease. But insulin is not a cure, nor does it prevent the possibility of the disease’s devastating effects, which can include kidney failure, blindness, heart disease, stroke, amputation, and pregnancy complications. JDRF is dedicated to finding a cure for type 1 and removing the burdens and threats that the disease carries.
A global leader in type 1 diabetes research
JDRF funding and leadership is associated with most major scientific breakthroughs in type 1 diabetes research to date. By funding more type 1 research than any other nonprofit, JDRF is a global leader in advancing type 1 diabetes science.
JDRF directed nearly $107 million to such research in fiscal year 2010 (with over $3 million of that coming from the Piedmont Triad Chapter), bringing its total research funding to more than $1.5 billion since its founding in 1970.
What does hope look like?
Click here to learn about—and participate in—JDRF’s extensive roster of type 1 human clinical trials.